Treatment
Β-globin Restored Autologous Hematopoietic Stem Cells clinical trials
We’re tracking 3 recruiting studies that include Β-globin Restored Autologous Hematopoietic Stem Cells, each written for real people, not researchers, below.
Recruiting studies
- NCT05864170RecruitingEarly Phase 1
Tested injection for severe transfusion-dependent thalassemia
This early-stage study tests the safety and possible benefits of an injection called HGI-001 for people with severe transfusion-dependent beta thalassemia. It may help by preparing you for stem cell transplant, but you must meet several health and lab criteria and be able to return often for follow-up tests.
Shenzhen, GuangdongAges 18–35 - NCT05745532RecruitingEarly Phase 1
Autologous stem cell treatment to improve beta thalassemia major
This early-phase trial tests a new way to restore working blood-making cells using your own stem cells for people with transfusion-dependent beta thalassemia major. The goal is to improve safety and blood results, and possibly reduce problems from the disease.
Shenzhen, GuangdongAges 8–16 - NCT06655662RecruitingPhase 1
Gene therapy for severe beta-thalassemia
This trial tests a one-time gene therapy using your own blood stem cells to treat severe beta-thalassemia. It may help you stop needing regular blood transfusions.
GuangxiAges 6–35
What Β-globin Restored Autologous Hematopoietic Stem Cells is being studied for
Conditions with recruiting Β-globin Restored Autologous Hematopoietic Stem Cells studies.
Common questions
- Are there clinical trials studying Β-globin Restored Autologous Hematopoietic Stem Cells?
- Yes. Clin2 currently lists 3 recruiting studies that include Β-globin Restored Autologous Hematopoietic Stem Cells, drawn from the U.S. registry and rewritten for real people so you can see what each is testing and who it's for.
- How do I know if I qualify for a Β-globin Restored Autologous Hematopoietic Stem Cells trial?
- Each study lists its own eligibility criteria — rules about condition, age, and prior treatments. On every Clin2 trial page we explain these in plain language and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Is Β-globin Restored Autologous Hematopoietic Stem Cells an approved treatment?
- A drug being studied in a trial may be investigational (still being tested) or already approved and being studied for a new use. Each study page explains what phase it's in. Clin2 does not provide medical advice — talk with your doctor about whether Β-globin Restored Autologous Hematopoietic Stem Cells or a specific trial is right for you.
Related treatments
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. A drug appearing here is being studied in a trial and may be investigational. Talk with your doctor about whether a specific treatment or trial is right for you.